Bonita L. Blake

Directed Evolution of a Novel Adeno-associated Virus (AAV) Vector That Crosses the Seizure-compromised Blood–Brain Barrier (BBB)

Steven J. Gray, Bonita L. Blake, Hugh E. Criswell et al. · Molecular Therapy · 2009 · 186 citations · Full text

Life Sciences, Biotechnology, Neuroscience +17

Olfactory Toxicity of Methimazole: Dose-Response and Structure-Activity Studies and Characterization of Flavin-Containing Monooxygenase Activity in the Long-Evans Rat Olfactory Mucosa

Mary Beth Genter, Nora J. Deamer, Bonita L. Blake et al. · Toxicologic Pathology · 1995 · 111 citations

Veterinary Medicine, Pharmacology, Toxicology +16

Functional Selectivity of Dopamine Receptor Agonists. II. Actions of Dihydrexidine in D2L Receptor-Transfected MN9D Cells and Pituitary Lactotrophs

Jason D. Kilts, Hilary S. Connery, Elaine G. Arrington et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 83 citations · Full text

Medicine, Biochemistry, Pharmacology +14

Opposing actions of hippocampus TNFα receptors on limbic seizure susceptibility

Marc S. Weinberg, Bonita L. Blake, Thomas J. McCown · Experimental Neurology · 2013 · 64 citations

Medicine, Neurobiology, Neuroscience +14

Sustained Extracellular Signal-Regulated Kinase 1/2 Phosphorylation in Neonate 6-Hydroxydopamine-Lesioned Rats after Repeated D₁-Dopamine Receptor Agonist Administration: Implications for NMDA Receptor Involvement

Sophia T. Papadeas, Bonita L. Blake, Darin J. Knapp et al. · Journal of Neuroscience · 2004 · 44 citations · Full text

Medicine, Neuroscience, Pharmacology +17